基本信息
浏览量:167
职业迁徙
个人简介
Dr. Gragoudas is an international authority in retinal diseases and intraocular tumors. His translational research has benefited countless patients with ocular malignancies and retinal neovascular diseases. His early translational work focused on uveal melanoma, for which he pioneered the use of proton beam irradiation—a highly successful treatment that has been used in over 15,000 patients to date as a proven and safe alternative to enucleation (removal of the eye). Along with refining proton beam therapy, Dr. Gragoudas also has studied the epidemiology, genetics, and molecular biology of uveal melanoma to further improve diagnosis and treatment for this potentially fatal disease.
With a long-standing interest in retinal disorders, Dr. Gragoudas helped pioneer vascular-targeting therapies for neovascular diseases of the eye. In collaboration with Dr. Joan Miller, co-recipient of the 2014 Champalimaud Vision Award, Dr. Gragoudas developed photodynamic therapy using the light-sensitive dye verteporfin (Visudyne®). He was instrumental in designing and executing the early clinical studies, and was an integral member of the study and writing groups for the large clinical trials. Based on these large clinical trials, photodynamic therapy using Visudyne® became the first AMD treatment approved by the US Food and Drug Administration and international drug regulatory agencies.
With a long-standing interest in retinal disorders, Dr. Gragoudas helped pioneer vascular-targeting therapies for neovascular diseases of the eye. In collaboration with Dr. Joan Miller, co-recipient of the 2014 Champalimaud Vision Award, Dr. Gragoudas developed photodynamic therapy using the light-sensitive dye verteporfin (Visudyne®). He was instrumental in designing and executing the early clinical studies, and was an integral member of the study and writing groups for the large clinical trials. Based on these large clinical trials, photodynamic therapy using Visudyne® became the first AMD treatment approved by the US Food and Drug Administration and international drug regulatory agencies.
研究兴趣
论文共 615 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Takuto Sato, Kamaneh Montazeri,Evangelos S Gragoudas,Anne Marie Lane,Mary Beth Aronow,Justine V Cohen,Genevieve M Boland, Eric Banks, Christopher Kachulis, Mark Fleharty, Carrie Cibulskis,Aleigha Lawless,
JCO precision oncology (2024): e2300368-e2300368
Megan S. Steinkerchner,Caleb D. Hartley, Anne M. Lane,Frances Wu,Evangelos S. Gragoudas,Ivana K. Kim
Ophthalmology Retina (2024)
Caleb Hartley, Ronan McCarthy,Anne Lane, Ashley Go, Disorn Suwajanakorn,Frances Wu,Mary Aronow,Evangelos Gragoudas,Ivana Kim
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEno. 8 (2023)
引用0浏览0引用
0
0
Ashley Go, Disorn Suwajanakorn,Anne Marie Lane,Caleb Hartley,Monica Oxenreiter,Mary E. Aronow,Evangelos S. Gragoudas,Ivana K. Kim
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEno. 8 (2023): 319-325
British Journal of Ophthalmologypp.bjo-323133, (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn